• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Copaxone

Turkey flag Turkey magnifying glass Turkey investigation
Pharma

Teva's patent and communications strategies in Turkey face probe

But Teva's foot in both realms is now being highlighted as it faces scrutiny over whether it stymied generics to its innovative drugs in Turkey. 
Fraiser Kansteiner , Zoey Becker Aug 26, 2026 8:15am
FDA

Teva's Copaxone gets boxed warning for anaphylaxis risk

Jan 23, 2025 7:52am
European Commission EU Europe Brussels EC

Teva hit with €463M fine over Copaxone misconduct claims in EU

Oct 31, 2024 10:45am
settlement

Teva to pay $450M to settle longstanding kickback allegations

Oct 11, 2024 9:23am
A gavel in the foreground with the scale of justice in the background

Teva faces fresh Copaxone kickbacks lawsuit

Aug 20, 2024 1:12pm
red light stop light street traffic signal

Viatris, Mapi's long-acting MS drug rebuffed by FDA

Mar 11, 2024 11:11am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings